Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADRC for Postoperative Bladder Neck Contracture
NCT02869061Phase 2Unknown
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose-derived stem/stromal cells in bladder neck contracture (BNC). Primary endpoints: Serious adverse events at 4 weeks and Serious adverse reactions at 4 weeks. Status: unknown.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
bladder neck contracture (BNC)
Beyond the preview
Go deeper on NCT02869061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02869061.